Iron‐Cobalt Alloy@Graphene‐Engineered Milk Extracellular Vesicles for Gastric Retentive Drug Delivery
ChemBioChem · 2025
DOI: 10.1002/cbic.202401048 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Yijing Wen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, Coll…. Hauptthemen laut MEDLINE: Graphite, Extracellular Vesicles, Cobalt, Iron. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Science and Technology Innovation Program of Hunan Province.
Abstract (Originalsprache)
Oral drug delivery is widely used for treating gastric diseases as it allows drugs to act directly on gastric lesions, thereby improving therapeutic outcomes. However, its efficacy is hindered by the specific gastric environment, such as the gastric mucosal barrier, which limits drug penetration, and the short gastric emptying time, which results in transient residence time. Raw milk‐derived extracellular vesicles (M‐EVs) offer promise as a gastric drug delivery platform. Their high cellular affinity, stability under gastrointestinal conditions, and ability to protect drugs from acidic and enzymatic degradation make them suitable for this purpose. Incorporating mangetic nanoparticles encapsulated in M‐EV provides magnetic navigation and active mucosal penetration capabilities. Herein, we developed a gastric drug delivery system based on iron‐cobalt alloy@graphene (FeCo@G)‐engineered M‐EV (M‐FNP). M‐FNP serves as a versatile drug carrier that can load both small molecules and proteins through simple physical approach. And it demonstrates stability in the simulated gastric fluid system for at least 6 hours. Under magnetic field guidance, it penetrates the simulated mucosal layer and is internalized by cells within 4 hours significantly enhancing cellular drug uptake. M‐FNP is expected to serve as an innovative drug delivery platform with enhanced retention capabilities within the stomach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, College of Biology, Aptamer Engineering Center of Hunan Province, Hunan Un…
- Institut des Matériaux Poreux de Paris, ENS, ESPCI Paris, CNRS, PSL University, Paris, 75005, France.
- College of Environmental Science and Engineering, Hunan University, Changsha, Hunan, 410082, China.
ORCID-Profile: Zhuo Chen
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Science and Technology Innovation Program of Hunan Province
- The National Funded Postdoctoral Researcher Program of China
Zitieren
APA
Wen, Y., Shi, R., Cheng, Y., Zhang, Y., Zhao, L., Xia, X., Meng, X., & Chen, Z. (2025). Iron‐Cobalt Alloy@Graphene‐Engineered Milk Extracellular Vesicles for Gastric Retentive Drug Delivery. ChemBioChem. https://doi.org/10.1002/cbic.202401048
Vancouver
Wen Y, Shi R, Cheng Y, Zhang Y, Zhao L, Xia X, et al. Iron‐Cobalt Alloy@Graphene‐Engineered Milk Extracellular Vesicles for Gastric Retentive Drug Delivery. ChemBioChem. 2025. doi:10.1002/cbic.202401048
BibTeX
@article{Wen2025,
author = {Wen, Yijing and Shi, Rui and Cheng, Yuqi and Zhang, Yi and Zhao, Lingjin and Xia, Xin and Meng, Xiangxian and Chen, Zhuo},
title = {Iron‐Cobalt Alloy@Graphene‐Engineered Milk Extracellular Vesicles for Gastric Retentive Drug Delivery},
journal = {ChemBioChem},
year = {2025},
doi = {10.1002/cbic.202401048}
}
EUVIMED